Apolipoproteins induced by an antimitotic agent.
D000818:Animals; D001053:Apolipoproteins / Q000097:blood* / Q000378:metabolism; D002352:Carrier Proteins / Q000097:blood; D053480:Cholesterol Ester Transfer Proteins; D002788:Cholesterol Esters / Q000097:blood; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000494:pharmacology*; D006023:Glycoproteins; D006937:Hypercholesterolemia / Q000097:blood / Q000139:chemically induced; D007275:Injections, Intravenous; D007525:Isoelectric Focusing; D008071:Lipoprotein Lipase / Q000378:metabolism; D008077:Lipoproteins, LDL / Q000097:blood / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000097:blood / Q000378:metabolism; D008938:Mitosis / Q000187:drug effects*; D011817:Rabbits
D001053:Apolipoproteins; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D002788:Cholesterol Esters; D006023:Glycoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D003520:Cyclophosphamide; D008071:Lipoprotein Lipase